Literature DB >> 12674117

Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?

Pierre Asfar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674117     DOI: 10.1007/s00134-002-1590-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Vasopressin pressor hypersensitivity in vasodilatory septic shock.

Authors:  D W Landry; H R Levin; E M Gallant; S Seo; D D'Alessandro; M C Oz; J A Oliver
Journal:  Crit Care Med       Date:  1997-08       Impact factor: 7.598

Review 2.  Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches.

Authors:  B Chernow; B L Roth
Journal:  Circ Shock       Date:  1986

3.  Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.

Authors:  C Bernadich; J C Bandi; P Melin; J Bosch
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

4.  Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.

Authors:  M D Schaller; B Waeber; J Nussberger; H R Brunner
Journal:  Am J Physiol       Date:  1985-12

5.  Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs.

Authors:  G R Heyndrickx; D H Boettcher; S F Vatner
Journal:  Am J Physiol       Date:  1976-11

6.  Evidence supporting a role for endogenous vasopressin in natural suppression of fever in the sheep.

Authors:  K E Cooper; N W Kasting; K Lederis; W L Veale
Journal:  J Physiol       Date:  1979-10       Impact factor: 5.182

7.  Evidence supporting a role for endogenous vasopressin in fever suppression in the rat.

Authors:  K E Cooper; A M Naylor; W L Veale
Journal:  J Physiol       Date:  1987-06       Impact factor: 5.182

8.  Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.

Authors:  G L Kovács; D De Wied
Journal:  Neuroendocrinology       Date:  1983-10       Impact factor: 4.914

9.  Vasopressin release during sepsis and septic shock in baboons and dogs.

Authors:  M F Wilson; D J Brackett; L B Hinshaw; P Tompkins; L T Archer; B A Benjamin
Journal:  Surg Gynecol Obstet       Date:  1981-12

10.  The role of endorphins and vasopressin in canine endotoxin shock.

Authors:  J L Cronenwett; B S Baver-Neff; R J Grekin; J N Sheagren
Journal:  J Surg Res       Date:  1986-12       Impact factor: 2.192

View more
  7 in total

1.  Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar.

Authors:  Bart L De Keulenaer; Dianne P Stephens
Journal:  Intensive Care Med       Date:  2003-03-25       Impact factor: 17.440

Review 2.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

3.  Admission plasma vasopressin levels in children with meningococcal septic shock.

Authors:  F Leclerc; E Walter-Nicolet; S Leteurtre; O Noizet; A Sadik; R Cremer; C Fourier
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

4.  Terlipressin for catecholamine-resistant septic shock in children.

Authors:  Antonio Rodríguez-Núñez; Manuel Fernández-Sanmartín; Federico Martinón-Torres; Natalia González-Alonso; José María Martinón-Sánchez
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 5.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

6.  Using terlipressin in a pediatric patient with septic shock resistant to catecholamines.

Authors:  Seher Erdogan; Mehmet Bosnak
Journal:  North Clin Istanb       Date:  2017-11-01

7.  Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.

Authors:  Antonio Rodríguez-Núñez; Jesús López-Herce; Javier Gil-Antón; Arturo Hernández; Corsino Rey
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.